Abstract:Abstract Aim: Hepatocellular carcinoma (HCC) is a dynamically developing disease. However, the molecular and evolutionary mechanism underlying the development of human non-malignant liver disease into HCC remains largely unknown. Methods: We performed whole-genome sequencing studies on 3 different types of samples (e.g. liver cirrhosis (LC), dysplastic liver nodules (DN), and hepatocellular carcinoma (HCC)) which were collected simultaneously from each of 8 liver cancer patients. Bioinformatics analysis was performed on somatic mutations, mutational signatures, copy number alterations, structure variants, telomere length, and phylogenetic trees. Results: Surprisingly, few passenger mutations were shared across LC, DN and HCC samples within each patient. Compared with the non-malignant LC and DN samples, HCC was characterized by significantly greater number of somatic mutations (particularly oncogenic mutations), copy number alterations, genomic rearrangements, as well as shorter telomeres. HCC exhibited much similar mutational signatures as dysplastic nodules but different from background cirrhotic liver. Several mutational signatures (e.g. COSMIC signatures 16, 22, 24) were substantially more active in tumor and DN samples than LC, while some mutational signatures (e.g. signatures 5, 8) were universal and equally active in both non-malignant hepatocytes and HCC. Most somatic copy number alterations (SCNAs) were only observed in HCC and no overlap across different samples was found. In contrast to universal subclonal SCNAs, minimal subclonal diversification of mutations was identified in HCC, implying the majority of mutations are acquired at the earliest stages. Conclusions: HCC can be characterized by punctuated evolution of mutations in short bursts followed by subclonal diversification driven by SCNAs. Despite little overlap of mutations, the mutational context indicates a common mutagenesis mechanism underlying HCC and DN, which is different from LC. Citation Format: Xiangyu Zhang, Ran Cao, Kaiqian Zhou, Xinyu Wang, Cheng Zhou, Feiyu Chen, Hua Bao, Xue Wu, Yang W. Shao, Jia Fan, Jian Zhou, Zheng Wang. Comprehensive genomic insights into dynamic mechanism underlying the development of non-malignant human liver disease into hepatocellular carcinoma [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr LB-309.

Hyperpolyploidization of Hepatocyte Initiates Preneoplastic Lesion Formation in the Liver

The Controversial Role of Polyploidy in Hepatocellular Carcinoma

Abstract LB-309: Comprehensive Genomic Insights into Dynamic Mechanism Underlying the Development of Non-Malignant Human Liver Disease into Hepatocellular Carcinoma

Transforming primary human hepatocytes into hepatocellular carcinoma with genetically defined factors

Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.

The Mutational and Transcriptional Landscapes of Hepatocarcinogenesis in a Rat Model

Hepatocyte polyploidization and its association with pathophysiological processes

Initiation of aberrant DNA methylation patterns and heterogeneity in precancerous lesions of human hepatocellular cancer

Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis

Transgenic CHD1L Expression in Mouse Induces Spontaneous Tumors

Single-Cell DNA Sequencing Reveals Punctuated and Gradual Clonal Evolution in Hepatocellular Carcinoma

Liver cancer initiation is dependent on metabolic zonation but decoupled from premalignant clonal expansion

Uncovering Biological Factors That Regulate Hepatocellular Carcinoma Growth Using Patient‐Derived Xenograft Assays

Intrahepatic hepatitis B virus large surface antigen induces hepatocyte hyperploidy via failure of cytokinesis

GPNMB+ Gal-3+ Hepatic Parenchymal Cells Promote Immunosuppression and Hepatocellular Carcinogenesis.

Translationally Controlled Tumor Protein Induces Mitotic Defects and Chromosome Missegregation in Hepatocellular Carcinoma Development

Data from MPHOSPH1: A Potential Therapeutic Target for Hepatocellular Carcinoma

Upregulation of LAPTM4B-35 promotes malignant transformation and tumorigenesis in L02 human liver cell line.

BNIP3L-Dependent Mitophagy Promotes HBx-Induced Cancer Stemness of Hepatocellular Carcinoma Cells via Glycolysis Metabolism Reprogramming

Identification of Warning Transition Points from Hepatitis B to Hepatocellular Carcinoma Based on Mutation Accumulation for the Early Diagnosis and Potential Drug Treatment of HBV-HCC

Aberrant Enhancer Hypomethylation Contributes to Hepatic Carcinogenesis Through Global Transcriptional Reprogramming